Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Days Sales Outstanding

: 97.47 (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

Aspen Pharmacare Holdings's average Accounts Receivable for the six months ended in Dec. 2023 was $606 Mil. Aspen Pharmacare Holdings's Revenue for the six months ended in Dec. 2023 was $1,135 Mil. Hence, Aspen Pharmacare Holdings's Days Sales Outstanding for the six months ended in Dec. 2023 was 97.47.

The historical rank and industry rank for Aspen Pharmacare Holdings's Days Sales Outstanding or its related term are showing as below:

APNHY' s Days Sales Outstanding Range Over the Past 10 Years
Min: 75.36 Med: 83.89 Max: 105.21
Current: 93.84

During the past 13 years, Aspen Pharmacare Holdings's highest Days Sales Outstanding was 105.21. The lowest was 75.36. And the median was 83.89.

APNHY's Days Sales Outstanding is ranked worse than
70.1% of 1000 companies
in the Drug Manufacturers industry
Industry Median: 72.185 vs APNHY: 93.84

Aspen Pharmacare Holdings's Days Sales Outstanding declined from Dec. 2022 (105.19) to Dec. 2023 (97.47).

Aspen Pharmacare Holdings Days Sales Outstanding Historical Data

The historical data trend for Aspen Pharmacare Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aspen Pharmacare Holdings Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Days Sales Outstanding

100.47

106.32

72.72

80.33

89.02

Aspen Pharmacare Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding																101.43	99.35	105.19	102.70	97.47

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Aspen Pharmacare Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aspen Pharmacare Holdings Days Sales Outstanding Distribution

For the Drug Manufacturers industry and Healthcare sector, Aspen Pharmacare Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Aspen Pharmacare Holdings's Days Sales Outstanding falls into.

Aspen Pharmacare Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Aspen Pharmacare Holdings's Days Sales Outstanding for the fiscal year that ended in Jun. 2023 is calculated as

	Days Sales Outstanding (A: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (521.234	+	538.123)	/	2 )	/	2171.749	*	365
=	529.6785					/	2171.749	*	365
=	89.02

Aspen Pharmacare Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (538.123	+	673.865)	/	2 )	/	1134.612	*	365 / 2
=	605.994					/	1134.612	*	365 / 2
=	97.47

Aspen Pharmacare Holdings (OTCPK:APNHY) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Aspen Pharmacare Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Aspen Pharmacare Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aspen Pharmacare Holdings Ltd (OTCPK:APNHY) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

APN:South Africa

Address

Douglas Saunders Drive, Aspen Place, 9 Rydall Vale Park, La Lucia Ridge, Durban, NL, ZAF

Website

https://www.aspenpharma.com

Aspen Pharmacare Holdings Ltd is a specialty pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both API and finished dose form. The company focuses on a broad range of post-patent, branded medicines and domestic brands spanning many therapeutic areas. The company has four business segments such as Active Pharmaceutical Ingredients (API) - this segment includes the API Chemicals business and non-heparin biochemical API business, Heparin - this segment includes the full value chain contribution from all heparin containing products including API and Finished Dose. Form (FDF) sales Key products include the Fraxiparine and MonoEmbolex heparin containing FDF products and FDF Steriles segment.

Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Headlines

From GuruFocus

Aspiring for Aspen Pharmacare Holdings Ltd's Dividend: A Comprehensive Analysis

By GuruFocus Research • 09-21-2023

Value Idea Contest: Aspen Pharmacare

By Matthew Sipos Matthew Sipos • 03-17-2019